When we hear the word “nicotine,” most of us think about vaping, cigarettes, addiction, and lung cancer. But beneath this stigma lies an interesting paradox: nicotine, the same compound that makes ...
SaveHealth reports on advancements in dementia medications, highlighting new treatments that modify disease progression and improve patient quality of life.
Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company developing therapies for neurodegenerative diseases, today announced it will present new clinical insights on ...
Prices $35 Million Oversubscribed Public Offering. Alpha Cognition (NASDAQ: ACOG) , a commercial-stage biopharmaceutical company focused on treatments for neurodegenerative diseases, announced the pri ...
Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout ...
Alpha Cognition Inc. (Nasdaq: ACOG) (the “Company”), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for ...
Australian skinks possess a remarkable natural immunity to deadly snake venom, stemming from a genetic mutation in a critical ...
Antivenom can save lives after mamba bites—but new research shows it may unmask a second paralysis, leaving patients with ...
e-cigarettes continue to be promoted as a smoking cessation by some, while new research highlights dangers for vaping in ...
Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout anticipated in early Q4 2025 Cash runway extended through fisca ...
The stock options are subject to the terms and conditions of the 2024 Equity Inducement Plan, as well as the terms and conditions of the stock option agreement covering the grant and were made as an ...
Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by Bay Street pros, advisors and Canadians who invest on their own, they help ...